These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4071420)

  • 1. [Hypotensive and diuretic effect of heparin in patients with glomerulonephritis].
    Kutyrina IM; Nikishova TA; Tareeva IE
    Ter Arkh; 1985; 57(6):78-81. PubMed ID: 4071420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of heparin-induced aldosterone deficiency on renal function in patients with chronic glomerulonephritis.
    Kutyrina IM; Nikishova TA; Tareyeva IE
    Nephrol Dial Transplant; 1987; 2(4):219-23. PubMed ID: 3118260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Shvetsov MIu; Medvedeva TIu; Kozlovskaia NL; Miroshnichenko NG; Okonova EB; Shonichev DG; Rudenko TE; Stavrovskaia EV; Plieva OK
    Ter Arkh; 2001; 73(6):55-61. PubMed ID: 11521525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of the diuretic effect of heparin in chronic glomerulonephritis].
    Kutyrina IM; Nikishova TA; Lifshits NL; Aleksandrovskaia TN
    Ter Arkh; 1982; 54(7):42-6. PubMed ID: 7135221
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pulse therapy of patients with nephritis: effect on arterial pressure, electrolyte metabolism and the renin-aldosterone system].
    Klepikov PV; Kutyrina IM; Lukovnikova LP
    Ter Arkh; 1985; 57(6):81-3. PubMed ID: 3906991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of the diuretic and hypotensive action of certain preparations].
    Merkur'ev ND; Parakhnevich DT; Slepynin VI; Sokolov VI
    Voen Med Zh; 1974 Jan; (1):75-7. PubMed ID: 4617411
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Polymorphism studies of angiotensin converting enzyme gene in chronic glomerulonephritis].
    Kutyrina IM; Tareeva IE; Nosikov VV; Kamyshova ES; Gorashko NM; Chistiakov DA; Okonova EB; Troepol'skaia OV
    Ter Arkh; 1999; 71(6):30-4. PubMed ID: 10420452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive action of indapamide in hypertension of chronic renal failure].
    Meyrier A; Condamin MC
    Ann Cardiol Angeiol (Paris); 1994 Jan; 43(1):43-8. PubMed ID: 8172477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of hypotensive and pathogenetic therapy on the propulsive function of the heart in patients with glomerulonephritis].
    Zharko KP; Tarnakina TP; Akhmed DI
    Vrach Delo; 1989 Sep; (9):71-3. PubMed ID: 2609629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
    Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ohta S; Yoshii M; Minami J; Ono H; Numabe A; Matsuoka H
    Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J; Mladenović Lj
    Srp Arh Celok Lek; 1996; 124(9-10):246-50. PubMed ID: 9102857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical varieties of chronic glomerulonephritis and psychic characteristics of patients].
    Palamarchuk MI; Kukhtevich AV; Sokolova ED
    Ter Arkh; 2002; 74(6):49-52. PubMed ID: 12136484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of heparin on the renin-aldosterone system of patients with different clinical variants of chronic glomerulonephritis].
    Nikishova TA; Kutyrina IM; Tatsievskiĭ VA
    Urol Nefrol (Mosk); 1983; (4):52-6. PubMed ID: 6353731
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
    Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.